Shape shifters
Shape-shifting cancer cell discovery reveals potential skin cancer drug targets
A new technique allows scientists to see cells in 3D, and determine how different genes affect the shapes they adopt.
Shape-shifting cancer cell discovery reveals potential skin cancer drug targets
A new technique allows scientists to see cells in 3D, and determine how different genes affect the shapes they adopt.
Water persisted in Mars’ Gale crater for longer than previously thought
Imperial College London and NASA researchers have found signs that water was plentiful in Mars’ Gale crater for longer than previously thought.
1
Most Powerful Scanner of its Kind Recognised at Royal Brompton
Celebration of the installation of the most powerful scanner of its kind in the centre of diagnostic expertise at Royal Brompton Hospital.
‘Virtual biopsy’ uses AI to help doctors assess lung cancer
Imperial researchers have used artificial intelligence (AI) to extract information about the chemical makeup of lung tumours from medical scans.
New molecular toolkit boosts useful molecule production from yeast communities
Imperial scientists have built a toolkit to boost yeast’s ability to produce food, materials, and pharmaceuticals by engineering optimal behaviours.
Digistain gains clinical data to support rapid breast cancer assessment method
Digistain, a company with its roots at Imperial, has proven the worth of its breast cancer assessment method in a significant clinical trial.
Using deep learning to improve rapid cellular imaging
Researchers have combined neural networks with a wide range of microscopy techniques to improve how scientists peer into cells
Research shows how a tiny device in the ear canal can monitor heart health
A driving simulation study has shown we are one step closer to monitoring our heart health in real time via a tiny device worn in the ear.
Psychedelic therapy may help break the chains of gambling addiction
Researchers at Imperial’s Centre for Psychedelic Research are using brain imaging to understand addictions and devise new approaches to treating them.
Prostate cancer focal therapy is cost effective and may improve patient outcomes
Minimally invasive focal therapies for prostate cancer are associated with a lower overall cost and improved quality of life for patients.